Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission

Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission

Abstract Background To evaluate the efficacy and safety of treating HBV-positive mothers with telbivudine in early and middle pregnancy to prevent mother-to-infant HBV transmission. Methods The subject population comprised pregnant women with chronic hepatitis B (CHB; n = 188) from January 2013 to J...

Full description

Bibliographic Details
Main Authors: Weihui Sun, Shangfei Zhao, Lei Ma, Anhua Hao, Bo Zhao, Lin Zhou, Fengzhu Li, Mingquan Song
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Gastroenterology
Subjects:
Telbivudine
Hepatitis B virus
Mother-to-infant transmission
Fetus safety
Drug efficacy
Online Access:http://link.springer.com/article/10.1186/s12876-017-0608-7

Internet

http://link.springer.com/article/10.1186/s12876-017-0608-7

Similar Items